Learn bits
Science & Tech.
Komal gupta

24/02/22 13:20 PM IST

Source: PIB

CORBEVAX

In News

CORBEVAXTM is India’s first indigenously developed receptor binding domain protein sub-unit vaccine for COVID-19.

About the Vaccine:

  • This is developed by Biological E Limited with the support of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC). 
  • It is a recombinant protein vaccine which uses the receptor binding domain of the spike protein on the viral surface. 
  • It is a double dose vaccine that is administered intramuscularly and stored at 2° C to 8° C.

More Related Current Affairs View All

05 May

Key objectives of caste count

'The Union Cabinet has decided that the next Census will include questions on caste to its enumeration of India’s population, for the first time in almost a century. ' T

Read More

05 May

2 new genome-edited rice varieties

'Agriculture Minister Shivraj Singh Chouhan recently released two genome-edited varieties of rice, the first achievement of its kind in the country.' These two varieties, which

Read More

05 Mar

First-ever comprehensive survey of India’s river dolphins

'Prime Minister Narendra Modi released the results of the first-ever comprehensive population estimation of riverine dolphins – Gangetic and Indus dolphins – done in In

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps